The Calantic Digital Solutions platform
The Calantic Digital Solutions platform

Image source: Bayer

Sponsored • Expansion to AI market

Improving quantification and productivity

Bayer recently announced the launch of Calantic Digital Solutions, a new platform delivering access to digital applications, including artificial intelligence (AI) enabled programs for medical imaging.

The offering contains tools which aid radiologists and their teams to improve prioritization, lesion detection, quantification, and productivity. By providing access to AI radiology applications through the Calantic Digital Solutions platform Bayer expands its portfolio beyond contrast media, medical devices, software, and services. 

With Calantic Digital Solutions, we are entering the fastest growing segment in the radiology market and taking the next step on our way from a product provider to a solution provider

Gerd Krueger

Gerd Krueger, Head of Radiology at Bayer Pharmaceuticals, said: ‘With Calantic Digital Solutions, we are entering the fastest growing segment in the radiology market and taking the next step on our way from a product provider to a solution provider, following our mission to provide an ecosystem of third-party and Bayer products to deliver state-of-the art disease-oriented solutions for radiologists and their teams.’ 

Calantic Digital Solutions is a suite of digital radiology AI-enabled applications which provide assistance at critical steps within a patient’s treatment journey. The vendor-neutral, cloud-hosted platform includes a growing number of applications designed to aid in prioritization, lesion detection and quantification, as well as apps that automate routine tasks and measurements, improve the radiology suites’ workflow, and free up time for radiology staff. 

The offering is orchestrated by body region and procedure, initially focusing on thoracic and neurological diseases, such as pulmonary nodule detection. Another area of application is the triage of potential intracerebral hemorrhage (ICH) and large vessel occlusions (LVO), both of which can be associated with stroke. More disease-specific application packages will be added moving forward, the company announces. Bayer provides services around installation, configuration, and training of the platform and its applications. First launch markets will include the US and several European countries, with more regions to follow. 

The company sees increasing demand for innovation powered by AI: aging populations and changing lifestyles are leading to an increase in chronic conditions such as cardiovascular disease and cancer. Consequently, the need for medical imaging to detect diseases, guide treatment decisions and support therapy planning is growing. AI is the technology to meet these challenges, Bayer concludes, as it comes with the value proposition to accelerate diagnosis and increase the throughput of radiological examinations. 

More information: www.calantic.com 


Source: Bayer

01.10.2022

Read all latest stories

Related articles

Photo

Article • Philips presents portfolio update at ECR 2022

AI-powered MRI to increase imaging speed, reduce staff burden

The portfolio Philips presented at ECR 2022 revealed that the company not only advanced their products, but also listened to medical professionals and patients – and took their feedback to heart.

Photo

News • Diagnostic imaging

AI saves one hour of daily chest CT interpretation time

Incorporating AI support into clinical practice can reduce repetitive tasks, saving approximately one hour of chest CT interpretation time in a radiologist’s typical workday.

Photo

News • CT, MRI, X-ray, AI, PACS, endoscopy, ultrasound

Fujifilm Healthcare acquires Hitachi Diagnostic Imaging, presents new portfolio

At a virtual European event, Fujifilm Healthcare Europe presented a complete and integrated portfolio of diagnostic products and services, including CT, MRI, X-ray, AI, PACS, endoscopy and ultrasound…

Related products

Fujifilm · REiLI

Artificial Intelligence

Fujifilm · REiLI

FUJIFILM Europe GmbH
Agfa HealthCare – Rubee for AI

Artificial Intelligence

Agfa HealthCare – Rubee for AI

Agfa HealthCare
Fujifilm - FDR EX-M1 AI box

Aritificial Intelligence

Fujifilm - FDR EX-M1 AI box

FUJIFILM Europe GmbH
Fujifilm - Synapse Value

Business Intelligence

Fujifilm - Synapse Value

FUJIFILM Europe GmbH
Image Information Systems – iQ-4CLOUD

PACS

Image Information Systems – iQ-4CLOUD

IMAGE Information Systems Europe GmbH
Subscribe to Newsletter